AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Aug 26, 2024
35599_dirs_2024-08-26_0c807078-1d68-4cb5-b0d1-323751c43d5d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-08-23
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-23 | Common shares | G | 50000 | — | Disposed | 137471 | Direct |
| 2024-08-23 | Common shares | G | 16666 | — | Disposed | 120805 | Direct |
| 2024-08-23 | Common shares | G | 28372 | — | Disposed | 92433 | Direct |
Footnotes
F1: This transaction represents a donation of shares of the Issuer's Common Stock to a charity.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20